Efficacy of immunotherapy in KRAS-mutant advanced NSCLC: A real-world study in a Chinese population

BACKGROUND: Immunotherapy has improved the clinical outcomes of patients with advanced non-small cell lung cancer (NSCLC). However, in patients with Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations, the superior efficacy of immunotherapy has not been elucidated and especially in real-worl...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Lixiu, Guo, Jun, Kong, Li, Huang, Yong, Tang, Ning, Zhang, Juguang, Wang, Minglei, He, Xiaohan, Li, Zhenzhen, Peng, Yonggang, Wang, Zhehai, Han, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892536/
https://www.ncbi.nlm.nih.gov/pubmed/36741723
http://dx.doi.org/10.3389/fonc.2022.1070761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892536/
https://www.ncbi.nlm.nih.gov/pubmed/36741723
http://dx.doi.org/10.3389/fonc.2022.1070761

Ejemplares similares